Orphan designation: pelabresib monohydrate Treatment of myelofibrosis, 17/02/2025 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 12 March 2025 - 16:08

Orphan designation: pelabresib monohydrate Treatment of myelofibrosis, 17/02/2025 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-20-2247

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters